Found: 27
Select item for more details and to access through your institution.
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 781, doi. 10.1111/bjh.14954
- By:
- Publication type:
- Article
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 338, p. 1, doi. 10.1126/scitranslmed.aaf3006
- By:
- Publication type:
- Article
Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 2, p. 122, doi. 10.1016/j.clml.2023.09.008
- By:
- Publication type:
- Article
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e1, doi. 10.1016/j.clml.2022.02.001
- By:
- Publication type:
- Article
MPN-356: Transfusion Independence is Associated with Improved Overall Survival in Myelofibrosis Patients Receiving Momelotinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S364, doi. 10.1016/S2152-2650(21)01836-X
- By:
- Publication type:
- Article
Poster: MPN-356: Transfusion Independence is Associated with Improved Overall Survival in Myelofibrosis Patients Receiving Momelotinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S231, doi. 10.1016/S2152-2650(21)01456-7
- By:
- Publication type:
- Article
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S261, doi. 10.1016/j.clml.2018.07.172
- By:
- Publication type:
- Article
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health Span.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 2, p. 149, doi. 10.1007/s11899-020-00562-9
- By:
- Publication type:
- Article
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E49, doi. 10.1002/ajh.24980
- By:
- Publication type:
- Article
The association of histologic grade with acute graft-versus-host disease response and outcomes.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 683, doi. 10.1002/ajh.24749
- By:
- Publication type:
- Article
To Transplant or Not to Transplant for Adult Acute Myeloid Leukemia: An Ever-Evolving Decision.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 10, p. 1
- By:
- Publication type:
- Article
Let's talk about sex[uality]-related symptom burden in myeloproliferative neoplasms.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
The graceful exit or reluctant demise of the older adult with acute myeloid leukemia.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10073-w
- By:
- Publication type:
- Article
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Polycythemia Vera Management and Challenges in the Community Health Setting.
- Published in:
- Oncology, 2017, v. 92, n. 4, p. 179, doi. 10.1159/000454953
- By:
- Publication type:
- Article
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 901, doi. 10.1093/oncolo/oyad114
- By:
- Publication type:
- Article
Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 475, doi. 10.1634/theoncologist.2015-0380
- By:
- Publication type:
- Article
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 4, p. 448, doi. 10.1159/000520440
- By:
- Publication type:
- Article
Functional alterations in protein kinase C beta II expression in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2010, v. 23, n. 2, p. 216, doi. 10.1111/j.1755-148X.2009.00664.x
- By:
- Publication type:
- Article
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 9, p. 3722, doi. 10.1007/s12325-024-02928-4
- By:
- Publication type:
- Article